First human test for new drug begins
Knowledge-focused
Not yet recruiting
This is the first study in people for a new drug called HXN6005. Its main goal is to check if the drug is safe and how the body handles it. The study will enroll 40 healthy adults who will receive a single dose of either the drug or a placebo and be closely monitored for several …
Phase: PHASE1 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC